Glofitamab combined with GemOx shows promising survival benefits for patients with relapsed DLBCL, offering a new treatment option for those ineligible for transplants.

Updates on April 30, 2025, introduce changes to treatment regimens, sequencing flexibility, febrile neutropenia risk assessments, and drug-specific safety and supportive care guidance.

NCCN updates colon cancer guidelines, emphasizing testing for DPYD gene variants before initiating fluoropyrimidine-based chemotherapy.

The Version 3.2025 update adds tislelizumab-based regimens as preferred first-line treatments and introduces new dosing schedules for PD-L1–positive esophageal squamous cell carcinoma.

In older postmenopausal women, leukocyte count was found to be an independent predictor of long COVID symptom severity, highlighting its potential for use as a novel symptom biomarker.

In a clinical trial, tenecteplase was shown to be a comparable alternative to alteplase.

The label changes to buprenorphine extended-release injections can increase convenience and adherence for patients with moderate to severe opioid use disorder.

The test results are available in as little as 20 minutes.

Semaglutide has been approved for reducing kidney disease progression and cardiovascular risk in patients with type 2 diabetes, marking a significant advancement in CKD management.

Research suggests H5N1 may be spreading undetected among humans, particularly in veterinarians with frequent animal exposure.

All stakeholders should work together to determine and address drug shortages.

The approval makes the vaccine the first of its kind for this indication in the United States.

Amazon Pharmacy’s subscription service could cause sale disruptions for traditional retail pharmacies.

There were no substantial differences for the mindfulness with substance use or anxiety outcomes compared with the recovery control group.

The demands of the pharmacy profession—long hours, high stress, and emotional strain—can take a toll on pharmacists’ well-being.

Diabetic macular edema (DME) is the leading cause of new blindness in the US.

World Cancer Day, observed annually on February 4th, is a global initiative aimed at raising awareness, reducing stigma, and promoting equitable access to cancer care, with pharmacy professionals play...